New drug aims to free patients from frequent blood draws
NCT ID NCT07429266
Summary
This study is testing whether adding the experimental drug sapablursen to standard treatment helps people with polycythemia vera, a blood disorder that makes the blood too thick. The main goal is to see if the drug reduces the need for regular blood removal procedures (phlebotomies) to control the disease. About 250 participants will receive either the drug or a placebo along with their usual care for up to three years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLYCYTHEMIA VERA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.